Home > Income Statement > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Income Statement

EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year Income Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
INCOME :
Gross Sales ₹8,023 Cr₹6,786 Cr₹6,098 Cr₹5,979 Cr₹6,250 Cr
     Sales ₹7,844 Cr₹6,664 Cr₹5,986 Cr₹5,783 Cr₹6,136 Cr
     Job Work/ Contract Receipts -----
     Processing Charges / Service Income ₹91 Cr₹46 Cr₹57 Cr₹108 Cr₹65 Cr
     Revenue from property development -----
     Other Operational Income ₹88 Cr₹76 Cr₹55 Cr₹89 Cr₹50 Cr
Less: Excise Duty -----
Net Sales ₹7,896 Cr₹6,658 Cr₹5,986 Cr₹5,855 Cr₹6,056 Cr
EXPENDITURE :
Increase/Decrease in Stock ₹-264 Cr₹-190 Cr₹67 Cr₹-145 Cr₹-253 Cr
Raw Material Consumed ₹3,173 Cr₹2,447 Cr₹2,004 Cr₹2,173 Cr₹2,604 Cr
     Opening Raw Materials ₹323 Cr₹379 Cr₹420 Cr₹402 Cr₹337 Cr
     Purchases Raw Materials ₹1,413 Cr₹1,059 Cr₹916 Cr₹1,108 Cr₹1,331 Cr
     Closing Raw Materials ₹447 Cr₹323 Cr₹379 Cr₹420 Cr₹402 Cr
     Other Direct Purchases / Brought in cost ₹1,883 Cr₹1,332 Cr₹1,047 Cr₹1,082 Cr₹1,338 Cr
     Other raw material cost -----
Power & Fuel Cost ₹138 Cr₹120 Cr₹109 Cr₹97 Cr₹105 Cr
     Electricity & Power ₹138 Cr₹120 Cr₹109 Cr₹97 Cr₹105 Cr
     Oil, Fuel & Natural gas -----
     Coals etc -----
     Other power & fuel -----
Employee Cost ₹1,446 Cr₹1,292 Cr₹1,117 Cr₹1,012 Cr₹1,102 Cr
     Salaries, Wages & Bonus ₹1,266 Cr₹1,138 Cr₹977 Cr₹891 Cr₹967 Cr
     Contributions to EPF & Pension Funds ₹92 Cr₹74 Cr₹64 Cr₹59 Cr₹68 Cr
     Workmen and Staff Welfare Expenses ₹68 Cr₹59 Cr₹52 Cr₹41 Cr₹45 Cr
     Other Employees Cost ₹20 Cr₹21 Cr₹24 Cr₹22 Cr₹22 Cr
Other Manufacturing Expenses ₹589 Cr₹505 Cr₹451 Cr₹478 Cr₹408 Cr
     Sub-contracted / Out sourced services -----
     Processing Charges ₹105 Cr₹90 Cr₹59 Cr₹65 Cr₹58 Cr
     Repairs and Maintenance -----
     Packing Material Consumed ₹238 Cr₹219 Cr₹189 Cr₹206 Cr₹170 Cr
     Other Mfg Exp ₹247 Cr₹196 Cr₹202 Cr₹207 Cr₹180 Cr
General and Administration Expenses ₹561 Cr₹546 Cr₹484 Cr₹372 Cr₹369 Cr
     Rent , Rates & Taxes ₹55 Cr₹33 Cr₹21 Cr₹22 Cr₹24 Cr
     Insurance ₹27 Cr₹24 Cr₹23 Cr₹19 Cr₹21 Cr
     Printing and stationery ₹18 Cr₹17 Cr₹14 Cr₹12 Cr₹13 Cr
     Professional and legal fees ₹216 Cr₹232 Cr₹206 Cr₹155 Cr₹179 Cr
     Traveling and conveyance ₹164 Cr₹176 Cr₹157 Cr₹105 Cr₹75 Cr
     Other Administration ₹82 Cr₹65 Cr₹62 Cr₹58 Cr₹58 Cr
Selling and Distribution Expenses ₹593 Cr₹517 Cr₹415 Cr₹397 Cr₹357 Cr
     Advertisement & Sales Promotion ₹273 Cr₹259 Cr₹183 Cr₹163 Cr₹118 Cr
     Sales Commissions & Incentives ₹145 Cr₹130 Cr₹103 Cr₹90 Cr₹55 Cr
     Freight and Forwarding ₹174 Cr₹128 Cr₹129 Cr₹144 Cr₹102 Cr
     Handling and Clearing Charges ----₹82 Cr
     Other Selling Expenses -----
Miscellaneous Expenses ₹191 Cr₹193 Cr₹158 Cr₹142 Cr₹132 Cr
     Bad debts /advances written off ₹33 Cr₹52 Cr₹19 Cr₹1.96 Cr₹2.53 Cr
     Provision for doubtful debts --₹5.34 Cr₹5.58 Cr₹26 Cr
     Losson disposal of fixed assets(net) --₹0.33 Cr₹0.41 Cr-
     Losson foreign exchange fluctuations -----
     Losson sale of non-trade current investments -----
     Other Miscellaneous Expenses ₹158 Cr₹141 Cr₹133 Cr₹134 Cr₹103 Cr
Less: Expenses Capitalised -----
Total Expenditure ₹6,427 Cr₹5,429 Cr₹4,805 Cr₹4,525 Cr₹4,824 Cr
Operating Profit (Excl OI) ₹1,469 Cr₹1,230 Cr₹1,181 Cr₹1,330 Cr₹1,232 Cr
Other Income ₹73 Cr₹57 Cr₹46 Cr₹63 Cr₹35 Cr
     Interest Received --₹12 Cr₹10 Cr₹7.35 Cr
     Dividend Received -----
     Profit on sale of Fixed Assets ₹38 Cr₹7.19 Cr--₹0.42 Cr
     Profits on sale of Investments ₹5.48 Cr₹2.32 Cr₹0.12 Cr--
     Provision Written Back -----
     Foreign Exchange Gains ₹5.52 Cr₹13 Cr₹19 Cr₹37 Cr₹15 Cr
     Others ₹24 Cr₹34 Cr₹15 Cr₹16 Cr₹13 Cr
Operating Profit ₹1,542 Cr₹1,287 Cr₹1,227 Cr₹1,393 Cr₹1,267 Cr
Interest ₹176 Cr₹237 Cr₹214 Cr₹176 Cr₹198 Cr
     InterestonDebenture / Bonds -----
     Interest on Term Loan ₹43 Cr₹98 Cr₹79 Cr₹70 Cr₹97 Cr
     Intereston Fixed deposits -----
     Bank Charges etc ₹31 Cr₹28 Cr₹29 Cr₹29 Cr₹26 Cr
     Other Interest ₹102 Cr₹111 Cr₹106 Cr₹77 Cr₹76 Cr
PBDT ₹1,366 Cr₹1,050 Cr₹1,013 Cr₹1,217 Cr₹1,069 Cr
Depreciation ₹384 Cr₹312 Cr₹260 Cr₹245 Cr₹323 Cr
Profit Before Taxation & Exceptional Items ₹982 Cr₹737 Cr₹753 Cr₹973 Cr₹746 Cr
Exceptional Income / Expenses ₹-10 Cr₹-9.93 Cr₹-6.15 Cr-₹-89 Cr
Profit Before Tax ₹971 Cr₹727 Cr₹747 Cr₹973 Cr₹657 Cr
Provision for Tax ₹264 Cr₹200 Cr₹185 Cr₹270 Cr₹239 Cr
     Current Income Tax ₹286 Cr₹203 Cr₹169 Cr₹272 Cr₹197 Cr
     Deferred Tax ₹-26 Cr₹-12 Cr₹12 Cr₹-16 Cr₹38 Cr
     Other taxes ₹3.59 Cr₹7.98 Cr₹3.81 Cr₹14 Cr₹3.74 Cr
Profit After Tax ₹707 Cr₹528 Cr₹562 Cr₹703 Cr₹419 Cr
Extra items -----
Minority Interest ₹-26 Cr₹-29 Cr₹-30 Cr₹-40 Cr₹-26 Cr
Share of Associate -----
Other Consolidated Items -----
Consolidated Net Profit ₹681 Cr₹498 Cr₹532 Cr₹662 Cr₹392 Cr
Adjustments to PAT -----
Profit Balance B/F ₹2,634 Cr₹2,196 Cr₹1,695 Cr₹1,744 Cr₹1,369 Cr
Appropriations ₹3,315 Cr₹2,695 Cr₹2,227 Cr₹2,406 Cr₹1,761 Cr
     General Reserves -----
     Proposed Equity Dividend -----
     Corporate dividend tax -----
     Other Appropriation ₹2.39 Cr₹24 Cr₹13 Cr₹675 Cr₹17 Cr
Equity Dividend % -₹30.00₹20.00₹30.00₹10.00
Earnings Per Share ₹35.96₹27.50₹29.42₹36.62₹21.68
Adjusted EPS ₹35.96₹27.50₹29.42₹36.62₹21.68

Compare Income Statement of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹26,932.7 Cr 0.9% 14.3% 14.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,478.0 Cr -6.5% -4.7% -5.1% Stock Analytics
DIVIS LABORATORIES ₹162,845.0 Cr -7.1% -11.5% 32.7% Stock Analytics
CIPLA ₹120,121.0 Cr -4.3% -0.1% -1% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,327.0 Cr -5.8% 6.1% 13.3% Stock Analytics
DR REDDYS LABORATORIES ₹99,907.8 Cr -5.8% -6.8% -11% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

0.9%

14.3%

14.2%

SENSEX

-1.2%

-3.5%

-0.5%


You may also like the below Video Courses